117 related articles for article (PubMed ID: 8547071)
1. Band 4.2 Shiga: 317 CGC-->TGC in compound heterozygotes with 142 GCT-->ACT results in band 4.2 deficiency and microspherocytosis.
Kanzaki A; Yasunaga M; Okamoto N; Inoue T; Yawata A; Wada H; Andoh A; Hodohara K; Fujiyama Y; Bamba T
Br J Haematol; 1995 Oct; 91(2):333-40. PubMed ID: 8547071
[TBL] [Abstract][Full Text] [Related]
2. Electron microscopic evidence of impaired intramembrane particles and instability of the cytoskeletal network in band 4.2 deficiency in human red cells.
Yawata Y; Yawata A; Kanzaki A; Inoue T; Okamoto N; Uehira K; Yasunaga M; Nakamura Y
Cell Motil Cytoskeleton; 1996; 33(2):95-105. PubMed ID: 8635206
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation in the erythrocyte protein 4.2 gene of Japanese patients with hereditary spherocytosis (protein 4.2 Fukuoka).
Takaoka Y; Ideguchi H; Matsuda M; Sakamoto N; Takeuchi T; Fukumaki Y
Br J Haematol; 1994 Nov; 88(3):527-33. PubMed ID: 7819064
[TBL] [Abstract][Full Text] [Related]
4. Homozygous missense mutation (band 3 Fukuoka: G130R): a mild form of hereditary spherocytosis with near-normal band 3 content and minimal changes of membrane ultrastructure despite moderate protein 4.2 deficiency.
Inoue T; Kanzaki A; Kaku M; Yawata A; Takezono M; Okamoto N; Wada H; Sugihara T; Yamada O; Katayama Y; Nagata N; Yawata Y
Br J Haematol; 1998 Sep; 102(4):932-9. PubMed ID: 9734643
[TBL] [Abstract][Full Text] [Related]
5. Band 4.2 Komatsu: 523 GAT-->TAT (175 Asp-->Tyr) in exon 4 of the band 4.2 gene associated with total deficiency of band 4.2, hemolytic anemia with ovalostomatocytosis and marked disruption of the cytoskeletal network.
Kanzaki A; Yawata Y; Yawata A; Inoue T; Okamoto N; Wada H; Harano T; Harano K; Wilmotte R; Hayette S
Int J Hematol; 1995 Jun; 61(4):165-78. PubMed ID: 8547605
[TBL] [Abstract][Full Text] [Related]
6. A new β(0)-thalassemia mutation (codon 102, AAC>ATCAC) in coexistence with a heterozygous P4.2 Nippon gene.
Adhiyanto C; Yamashiro Y; Hattori Y; Nitta T; Hino M; Matar M; Takagi F; Kimoto M
Hemoglobin; 2013; 37(3):227-40. PubMed ID: 23600595
[TBL] [Abstract][Full Text] [Related]
7. Human erythrocyte protein 4.2 deficiency associated with hemolytic anemia and a homozygous 40glutamic acid-->lysine substitution in the cytoplasmic domain of band 3 (band 3Montefiore).
Rybicki AC; Qiu JJ; Musto S; Rosen NL; Nagel RL; Schwartz RS
Blood; 1993 Apr; 81(8):2155-65. PubMed ID: 8471774
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation causing an aberrant splicing in the protein 4.2 gene associated with hereditary spherocytosis (protein 4.2Notame).
Matsuda M; Hatano N; Ideguchi H; Takahira H; Fukumaki Y
Hum Mol Genet; 1995 Jul; 4(7):1187-91. PubMed ID: 8528207
[TBL] [Abstract][Full Text] [Related]
9. Heterogenous band 3 deficiency in hereditary spherocytosis related to different band 3 gene defects.
Dhermy D; Galand C; Bournier O; Boulanger L; Cynober T; Schismanoff PO; Bursaux E; Tchernia G; Boivin P; Garbarz M
Br J Haematol; 1997 Jul; 98(1):32-40. PubMed ID: 9233560
[TBL] [Abstract][Full Text] [Related]
10. Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex.
Bruce LJ; Ghosh S; King MJ; Layton DM; Mawby WJ; Stewart GW; Oldenborg PA; Delaunay J; Tanner MJ
Blood; 2002 Sep; 100(5):1878-85. PubMed ID: 12176912
[TBL] [Abstract][Full Text] [Related]
11. Partial pyruvate kinase deficiency aggravates the phenotypic expression of band 3 deficiency in a family with hereditary spherocytosis.
van Zwieten R; van Oirschot BA; Veldthuis M; Dobbe JG; Streekstra GJ; van Solinge WW; Schutgens RE; van Wijk R
Am J Hematol; 2015 Mar; 90(3):E35-9. PubMed ID: 25388786
[TBL] [Abstract][Full Text] [Related]
12. A genetic defect of erythrocyte band 4.2 protein associated with hereditary spherocytosis.
Ideguchi H; Nishimura J; Nawata H; Hamasaki N
Br J Haematol; 1990 Mar; 74(3):347-53. PubMed ID: 2139792
[TBL] [Abstract][Full Text] [Related]
13. Uniquely higher incidence of isolated or combined deficiency of band 3 and/or band 4.2 as the pathogenesis of autosomal dominantly inherited hereditary spherocytosis in the Japanese population.
Inoue T; Kanzaki A; Yawata A; Wada H; Okamoto N; Takahashi M; Sugihara T; Yamada O; Yawata Y
Int J Hematol; 1994 Dec; 60(4):227-38. PubMed ID: 7894027
[TBL] [Abstract][Full Text] [Related]
14. Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population.
Yawata Y; Kanzaki A; Yawata A; Doerfler W; Ozcan R; Eber SW
Int J Hematol; 2000 Feb; 71(2):118-35. PubMed ID: 10745622
[TBL] [Abstract][Full Text] [Related]
15. An alanine-to-threonine substitution in protein 4.2 cDNA is associated with a Japanese form of hereditary hemolytic anemia (protein 4.2NIPPON).
Bouhassira EE; Schwartz RS; Yawata Y; Ata K; Kanzaki A; Qiu JJ; Nagel RL; Rybicki AC
Blood; 1992 Apr; 79(7):1846-54. PubMed ID: 1558976
[TBL] [Abstract][Full Text] [Related]
16. Band 3Tambaú: a de novo mutation in the AE1 gene associated with hereditary spherocytosis. Implications for anion exchange and insertion into the red blood cell membrane.
Lima PR; Baratti MO; Chiattone ML; Costa FF; Saad ST
Eur J Haematol; 2005 May; 74(5):396-401. PubMed ID: 15813913
[TBL] [Abstract][Full Text] [Related]
17. [Alteration of erythrocyte membrane proteins in a family with hereditary spherocytosis].
Inoue F; Matsuyama R; Yoneyama S
Nihon Ketsueki Gakkai Zasshi; 1989 Nov; 52(7):1122-7. PubMed ID: 2618557
[TBL] [Abstract][Full Text] [Related]
18. Electron microscopic and physicobiochemical studies on disorganization of the cytoskeletal network and integral protein (band 3) in red cells of band 4.2 deficiency with a mutation (codon 142: GCT-->ACT).
Inoue T; Kanzaki A; Yawata A; Tsuji A; Ata K; Okamoto N; Wada H; Higo I; Sugihara T; Yamada O
Int J Hematol; 1994 Apr; 59(3):157-75. PubMed ID: 8011986
[TBL] [Abstract][Full Text] [Related]
19. Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation.
Inaba M; Yawata A; Koshino I; Sato K; Takeuchi M; Takakuwa Y; Manno S; Yawata Y; Kanzaki A; Sakai J; Ban A; Ono K; Maede Y
J Clin Invest; 1996 Apr; 97(8):1804-17. PubMed ID: 8621763
[TBL] [Abstract][Full Text] [Related]
20. Identification of red blood cell membrane defects in a patient with hereditary spherocytosis using next‑generation sequencing technology and matrix‑assisted laser desorption/ionization time‑of‑flight mass spectrometry.
Şener LT; Aktan M; Albeniz G; Şener A; Üstek D; Albeniz I
Mol Med Rep; 2019 May; 19(5):3912-3922. PubMed ID: 30896804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
